Professional Documents
Culture Documents
72
Symbol MRK MERCK & CO. INC. H&C Composite Score
Description Merck & Co., Inc. is a global pharmaceutical company that discovers, develops,
Neutral
manufactures, and markets a broad range of human and animal health products.
Merck's products include a treatment for elevated cholesterol, a treatment for
male pattern hair loss, a preventive treatment for osteoporosis, a treatment for
2.6
hypertension, and a treatment for allergic rhinitis.
$38
$37
$36
$35
$34
$33
$32
$31
5.0
Bull Trend Bear Trend
0.0
-5.0
1.5
Up / Down Volume Ratio
1.0
0.5
0.0
1,000
500
0
29-Nov-10 13-Dec-10 28-Dec-10 11-Jan-11 26-Jan-11 9-Feb-11 24-Feb-11 10-Mar-11 24-Mar-11
Volume x100,000
Fundamentals
MERCK & CO. INC.
1
Earnings Per Share 2
Reported Estimate Target Price 19 Reported Estimate
$1.20 $60
$1.00 $50
$0.80 $40
$0.60 $30
$0.40 $20
$0.20 $10
$0.00 $0
Total Revenues 1
Reported Estimate
Ownership EPS & Revenue Growth
Investment Advisor 89.54% Quarter EPS Growth Rev. Growth
$14,000
Pension Fund (ERISA) 4.01% FQ1 2009 -17% -8%
Hedge Fund Manager 2.45% FQ2 2009 -3% -3%
$12,000
Insurance Company 1.72% FQ3 2009 11% 2%
Mutual Fund Manager 1.30% FQ4 2009 -10% 67%
$10,000 Bank 0.56% FQ1 2010 12% 112%
Unclassified 0.15% FQ2 2010 4% 92%
$8,000 Corporation 0.13% FQ3 2010 -4% 84%
FQ4 2010 11% 20%
$6,000
Top Holders and % Outstanding Forward Growth Estimates
$4,000 CAPITAL WORLD INVEST 6.84% Quarter EPS Growth Rev. Growth
CAPITAL RESEARCH GLO 5.25% FQ1 2011 2% -1%
STATE STREET CORP 3.79% FQ2 2011 8% 1%
$2,000
VANGUARD GROUP INC 3.59% FQ3 2011 9% 1%
WELLINGTON MANAGEMEN 3.01% FQ4 2011 11% -1%
$0
BLACKROCK INSTITUTIO 2.52%
DODGE & COX 1.89%
FIDELITY MANAGEMENT 1.77%
Disclosure: This material is provided for information only and is not intended as a recommendation or an offer or solicitation for the purchase or sale of any security or financial instrument. This material is not a complete analysis of all material facts respecting any issuer, industry or
security or of your investment objectives, parameters, needs or financial situation, and therefore is not a sufficient basis alone on which to base an investment decision. Horowitz & Company clients may hold positions (long or short) in investments disc ussed. Please click for detailed
disclosures and additional information about our stock ratings and scoring.
3/24/2011